C3.ai: Founder Siebel Returns as CEO Amid Restructuring Turmoil

What happened

C3.ai announced that former CEO Thomas Siebel is returning to the chief executive role, effectively undoing the leadership change made less than a year ago when Stephen Ehikian took over. The move comes as the company struggles with collapsing revenue—down to $53.3M in Q3 FY26 from $98.8M a year earlier—and a 26% workforce reduction announced in February 2026. Siebel, who has been executive chairman and regularly selling shares, now takes direct control of a business burning over $56M in free cash flow per quarter. The return may signal board dissatisfaction with the prior CEO's restructuring execution, but it does not alter the core challenges: consumption-based pricing volatility, weak gross margins of 17%, and a depressed pipeline with only 14 initial production deployments. Investors should view this as a management reshuffle rather than a fundamental fix, as the company still needs to deliver opex reductions and federal deal conversion to stabilize.

Implication

The return of founder Thomas Siebel as CEO is a double-edged sword: it brings deep product and customer knowledge but also signals that the board lost confidence in the prior CEO's execution only nine months into the role. This leadership instability coincides with severe operational deterioration, making it harder to underwrite a turnaround timeline. Investors should focus on the next quarterly report due around June 2026: if opex does not step down meaningfully and cash burn remains above $50M per quarter, the restructuring thesis fails. Conversely, if Siebel can quickly realign the sales organization and convert federal/defense bookings into revenue, the stock could re-rate, but that is speculative at this stage. Given the existing 'potential sell' rating with an attractive entry around $7.50, buying now at $9.14 requires faith in leadership over fundamentals, which is not supported by hard data.

Thesis delta

Thesis remains unchanged: business is still in distress with declining revenue and high cash burn, and the CEO change adds execution risk. Leadership churn undermines credibility and could delay restructuring benefits, though Siebel's deep involvement may accelerate decision-making. No shift in conviction; the stock remains overvalued relative to anticipated cash flows until quarterly reports prove otherwise.